Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07661797 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase I Clinical Study of LNF2105 in Patients With Advanced Solid Tumors

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is a Phase I clinical trial evaluating the safety, tolerability, pharmacokinetic characteristics, and preliminary antitumor efficacy of LNF2105 in patients with advanced solid tumors.
Trial Details
NCT Number NCT07661797
Lead Sponsor Shandong New Time Pharmaceutical Co., LTD
Conditions
(from sponsor)		 Patients With Advanced Solid Tumors
Enrollment 294 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov